PULM Pulmatrix Inc

Pulmatrix Inc is is a clinical stage biotechnology company. The Company is engaged in discovery and development of a novel class of inhaled therapeutic products intended to prevent and treat respiratory diseases and infections.

$0.60  -0.01 (-2.14%)
As of 12/06/2021 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/21/2014
Outstanding shares:  56,249,062
Average volume:  562,835
Market cap:   $34,722,546
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    74584P202
ISIN:        US74584P2020
Valuation   (See tab for details)
PE ratio:   -1.78
PB ratio:   0.75
PS ratio:   7.35
Return on equity:   -35.71%
Net income %:   -341.54%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy